Oncology Today with Dr Neil Love
Oncology Today with Dr Neil Love
✓

Diffuse Large B-Cell Lymphoma — A Grand Rounds Program

· show notes
01:01:39
Podcasts
RSS
Link

ABOUT THIS EPISODE

Featuring a presentation by Dr Matthew Matasar, including the following topics:

  • Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) (0:00)
  • Clinician Survey Results Regarding First-Line Treatment of DLBCL (11:41)
  • Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL (16:01)
  • Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL (28:47)
  • Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL (34:34)
  • Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL (46:31)
  • Discussion of Questions from the Community (50:20)

CME information and select publications

Medicine
Education
Health & Fitness
Medicine
Science
English
United States
Use API to fetch this episode in JSON

IN THIS EPISODE

Edit these tags

SHOW NOTES 🔗

00:00:00Selection of First-Line Therapy for Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
00:11:41Clinician Survey Results Regarding First-Line Treatment of DLBCL
00:16:01Current and Future Roles of Monoclonal and Bispecific Antibodies in Therapy for Relapsed/Refractory (R/R) DLBCL
00:28:47Clinician Survey Results Regarding the Use of Monoclonal and Bispecific Antibodies for R/R DLBCL
00:34:34Evidence-Based Incorporation of Antibody-Drug Conjugates (ADCs) into the Management of R/R DLBCL
00:46:31Clinician Survey Results Regarding the Use of ADCs for R/R DLBCL
00:50:20Discussion of Questions from the Community

TRANSCRIPT 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

SEARCH PAST EPISODES

Search past episodes of Oncology Today with Dr Neil Love.
Embed this search bar to your website

OTHER EPISODES IN THIS PODCAST

Prostate Cancer — An Interview with Prof Karim Fizazi

Prostate Cancer — An Interview with Prof Karim Fizazi

Featuring an interview with Prof Karim Fizazi, including the following topics: Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00) Mechanism of action of opevesostat and potential role in castration-r…
01:01:31
SHARE
SAVE
Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3

Low-Grade Serous Ovarian Cancer — 5-Minute Journal Club: Microlearning Activity 3

Featuring perspectives from Prof Susana Banerjee, including the following topics: Overview of the biology and treatment of low-grade serous ovarian cancer (0:00) Mechanism of action of avutometinib/defactinib (10:16) RAMP 201 Trial: Avutometinib/defactinib in recurrent low-grade serous ovarian can…
00:32:19
SHARE
SAVE
Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Non-Hodgkin Lymphoma — A Roundtable Discussion on CD20 x CD3 Bispecific Antibodies and the Optimal Management of Cytokine Release Syndrome

Featuring perspectives from Dr Spencer Bachow, Dr Bhavana (Tina) Bhatnagar, Dr Jennifer Crombie, Dr Manali Kamdar and Ms Alexandra Lynch, co-moderated by Dr Bachow and Dr Bhatnagar, including the following topics: Introduction and Overview of Bispecific Antibodies in the Clinic (0:00) Current and …
01:58:22
SHARE
SAVE
Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies

Featuring a slide presentation from Dr Julia Rotow, including the following topics: Rationale and potential clinical role of PD-1/PD-L1 x vascular endothelial growth factor (VEGF) bispecific antibodies in the treatment of non-small cell lung cancer (NSCLC) (0:00) Key findings from the Phase III HA…
00:24:03
SHARE
SAVE
Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4

Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 4

Featuring perspectives from Prof Susana Banerjee, including the following topics: Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with response, asymptomatic creatine phosphokinase elevation and …
00:28:10
SHARE
SAVE
Disclaimer: The podcast and artwork embedded on this page are from Dr. Neil Love, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
PROMOTED
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
Bid on eBay

RECOMMENDATIONS
Use API to fetch this episode